Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling.

作者: Michael Röring , Ricarda Herr , Gina J Fiala , Katharina Heilmann , Sandra Braun

DOI: 10.1038/EMBOJ.2012.100

关键词:

摘要: The dimerisation of Raf kinases involves a central cluster within the kinase domain, dimer interface (DIF). Yet, importance DIF for signalling potential wild-type B-Raf (B-Raf(wt)) and its oncogenic counterparts remains unknown. Here, we show that plays pivotal role activity B-Raf(wt) several gain-of-function (g-o-f) mutants. In contrast, B-Raf(V600E), B-Raf(insT) B-Raf(G469A) oncoproteins are remarkably resistant to mutations in DIF. However, compared with B-Raf(wt), B-Raf(V600E) displays extended protomer contacts, increased homodimerisation incorporation into larger protein complexes. Raf-1(wt) mediated triggered by Ras as well paradoxical activation Raf-1 kinase-inactivated require an intact Surprisingly, is not required between B-Raf, which was inactivated D594A mutation, sorafenib or PLX4720. This suggests MEK/ERK represents two-step mechanism consisting DIF-dependent transactivation. Our data further implicate target against Ras-driven Raf-mediated (paradoxical) ERK activation.

参考文章(92)
Eftychia Oikonomou, Eleni Makrodouli, Maria Evagelidou, Tobias Joyce, Lesley Probert, Alexander Pintzas, BRAFV600E Efficient Transformation and Induction of Microsatellite Instability Versus KRASG12V Induction of Senescence Markers in Human Colon Cancer Cells Neoplasia. ,vol. 11, pp. 1116- 1131 ,(2009) , 10.1593/NEO.09514
Tamihiro Kamata, Catrin Pritchard, Mechanisms of aneuploidy induction by RAS and RAF oncogenes. American Journal of Cancer Research. ,vol. 1, pp. 955- 971 ,(2011)
G I Evan, G K Lewis, G Ramsay, J M Bishop, Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Molecular and Cellular Biology. ,vol. 5, pp. 3610- 3616 ,(1985) , 10.1128/MCB.5.12.3610
Ulf R. Rapp, H. Andreas Kalmes, Christoph K. Weber, Joseph R. Slupsky, Active Ras induces heterodimerization of cRaf and BRaf. Cancer Research. ,vol. 61, pp. 3595- 3598 ,(2001)
David B. Solit, Neal Rosen, Resistance to BRAF inhibition in melanomas. The New England Journal of Medicine. ,vol. 364, pp. 772- 774 ,(2011) , 10.1056/NEJMCIBR1013704
Gideon Bollag, Peter Hirth, James Tsai, Jiazhong Zhang, Prabha N. Ibrahim, Hanna Cho, Wayne Spevak, Chao Zhang, Ying Zhang, Gaston Habets, Elizabeth A. Burton, Bernice Wong, Garson Tsang, Brian L. West, Ben Powell, Rafe Shellooe, Adhirai Marimuthu, Hoa Nguyen, Kam Y. J. Zhang, Dean R. Artis, Joseph Schlessinger, Fei Su, Brian Higgins, Raman Iyer, Kurt D’Andrea, Astrid Koehler, Michael Stumm, Paul S. Lin, Richard J. Lee, Joseph Grippo, Igor Puzanov, Kevin B. Kim, Antoni Ribas, Grant A. McArthur, Jeffrey A. Sosman, Paul B. Chapman, Keith T. Flaherty, Xiaowei Xu, Katherine L. Nathanson, Keith Nolop, Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF -mutant melanoma Nature. ,vol. 467, pp. 596- 599 ,(2010) , 10.1038/NATURE09454
Anna Sarkozy, Claudio Carta, Sonia Moretti, Giuseppe Zampino, Maria C Digilio, Francesca Pantaleoni, Anna Paola Scioletti, Giorgia Esposito, Viviana Cordeddu, Francesca Lepri, Valentina Petrangeli, Maria L Dentici, Grazia MS Mancini, Angelo Selicorni, Cesare Rossi, Laura Mazzanti, Bruno Marino, Giovanni B Ferrero, Margherita Cirillo Silengo, Luigi Memo, Franco Stanzial, Francesca Faravelli, Liborio Stuppia, Efisio Puxeddu, Bruce D Gelb, Bruno Dallapiccola, Marco Tartaglia, None, Germline BRAF mutations in noonan, LEOPARD, and cardiofaciocutaneous Syndromes: Molecular diversity and associated phenotypic spectrum Human Mutation. ,vol. 30, pp. 695- 702 ,(2009) , 10.1002/HUMU.20955
A Clapéron, M Therrien, KSR and CNK: two scaffolds regulating RAS-mediated RAF activation Oncogene. ,vol. 26, pp. 3143- 3158 ,(2007) , 10.1038/SJ.ONC.1210408
Guillaume Gauchotte, Christophe Philippe, Stéphanie Lacomme, Brigitte Léotard, Marie-Pierre Wissler, Lila Allou, Bruno Toussaint, Marc Klein, Jean-Michel Vignaud, Aude Bressenot, BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis Pathology. ,vol. 43, pp. 447- 452 ,(2011) , 10.1097/PAT.0B013E3283486178
J. Yu, H. Deshmukh, R. J. Gutmann, R. J. Emnett, F. J. Rodriguez, M. A. Watson, R. Nagarajan, D. H. Gutmann, Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma Neurology. ,vol. 73, pp. 1526- 1531 ,(2009) , 10.1212/WNL.0B013E3181C0664A